Work

225 HER2 Protein Expression Heterogeneity Predicts Poor Response to Neoadjuvant Anti-HER2 Therapy in Breast Cancer: A Retrospective Cohort Study

Year: 2026
Type: article
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W7140143756
FWCI:
Cites:
Cited by:
Related to: